Cynata Therapeutics Health Care
Cancer Healthcare

$0.125 (0%)

High $0.13	Low $0.12	Trades 20	Turnover $48,049	Volume 400,697
30 June 2023 at 3:57pm

If you were already registered, log in here.

Market Cap (12-Nov) $4,377,747 (1,053rd)	Close (30-Jun) $0.125 0 (0%)	Volume (30-Jun) 400,697	Shortsold (13-May) 3,127 (0.00%) (661st)
52w High $0.435	52w Low $0.009	P/E -	EPS -0.04

Short Interest

ASIC data, 13 May 2026

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

661st

of 717 shorted ASX stocks

Peak Short

0.63%

Nov 2024

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	CYP CYP Ann: Grant Award to Fund Study of Cynata MSCs in Heart Disease
	1 (current) 2 3
	CYP CYP Ann: Appendix 3X - Janine Rolfe
	CYP CYP Ann: Appointment of Ms Janine Rolfe to the Cynata Board
	CYP CYP Ann: Preclinical study in coronary artery disease published
	CYP CYP Ann: Appendix 4G
	CYP CYP Ann: Corporate Governance Statement
	CYP CYP Ann: Appendix 4E & Annual Report
	CYP CYP Ann: Pipeline Update Following Strategic Portfolio Review
	CYP CYP Ann: Quarterly Activity Report & Appendix 4C
	CYP CYP Ann: Notice of Allowance for Cynata US Patent
	CYP CYP Article: Why this CEO brainstorms while sitting on a surfboard
	CYP CYP Ann: Further data supports potency of Cynata MSCs
	CYP CYP Ann: Cynata Adds New Site for MEND Clinical Trial
	CYP CYP Ann: FDA Clears Cynata IND for Phase 2 Trial in GvHD
	CYP CYP Ann: Notification of cessation of securities - CYP
	CYP CYP Ann: Quarterly Activity Report & Appendix 4C
	CYP CYP Ann: Cynata Advances Clinical Trial in Diabetic Foot Ulcers
	CYP CYP Ann: Updated Investor Presentation
	CYP CYP Ann: Notice of Allowance for Cynata Chinese Patent
	CYP CYP Ann: Appendix 4D & Half-Year Financial Statements
	CYP CYP Ann: Quarterly Activity Report & Appendix 4C
	CYP CYP Ann: Cynata Receives Decision to Grant a Patent in Japan
	CYP CYP Ann: Cynata Receives $832,677 R&D Tax Incentive Refund
	CYP CYP Ann: FUJIFILM Cellular Dynamics Executes Manufacturing Agreement
	CYP CYP Ann: Cynata Commences DFU Clinical Trial
	CYP CYP Ann: Change of Registry Address
	CYP CYP Ann: Appendix 3Y- Dr Stewart Washer
	CYP CYP Ann: Appendix 3Y - Dr Geoffrey Brooke
	CYP CYP Ann: Site Initiation Visit Completed for CYP DFU Clinical Trial
	CYP CYP Ann: Results of Annual General Meeting
	CYP CYP Ann: AGM Presentations
	CYP CYP Ann: Quarterly Activity Report & Appendix 4C
	CYP CYP Ann: Cynata Receives US$5m Fujifilm Fee
	CYP CYP Ann: Annual Report to shareholders
	CYP CYP Ann: Letter to Shareholders & Notice of Annual General Meeting
	CYP CYP Ann: Notification regarding unquoted securities - CYP
	CYP CYP Ann: DSMB Recommends Continuation of Cynata's MEND Trial
	CYP CYP Ann: Cynata Enters into a New Strategic Partnership with Fujifilm
	CYP CYP Ann: CYP Preclinical Heart Attack Study Published in Cytotherapy
	CYP CYP Ann: Date of AGM and Closing Date for Director Nominations
	CYP CYP Ann: Further Patents for Cynata Unique Cymerus Technology
	CYP CYP Ann: Further Canadian Patent for Cynata
	CYP CYP Ann: Appendix 4G
	CYP CYP Ann: Appendix 4E & Annual Report
	CYP CYP Ann: Cynata Receives Notice of Allowance from US Patent Office
	CYP CYP Ann: Quarterly Activity Report & Appendix 4C
	CYP CYP Ann: Cynata Appoints Dr Jolanta Airey Chief Medical Officer
	CYP CYP Ann: Change of Registered Office
	CYP CYP Ann: Ethics Approval for Cynata's Clinical Trial in DFU
	CYP CYP Ann: Progress Toward Clinical Trial in Diabetic Foot Ulcers

If you were already registered, log in here.

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

Upcoming Floats (8)

SUPER MINERALS LTD

S88

MAVERICK URANIUM LIMITED

MAV

Capability X

CX8

MATRIX CRITICAL MINERALS LIMITED

MTX $12m raise

Fitgenes

ATW $7.5m raise

RIO DE ORO CORP LTD

RDO $30m raise

Adbri Ltd

ABC $5m raise

RAMSAY GENERALE DE SANTE SA

RGS

Top

End of Day Prices

Date	Close	Volume	Change
12-Nov	$0.01	69,705	0.00 (7.14%)
11-Nov	$0.01	137,347	0.00 (6.67%)
09-Nov	$0.02	1,956,797	+0.00 (25.00%)
06-Nov	$0.01	323,065	0.00 (7.69%)
05-Nov	$0.01	727,106	0.00 (0.00%)
04-Nov	$0.01	13,149,608	+0.00 (30.00%)
03-Nov	$0.01	687,221	0.00 (9.09%)
02-Nov	$0.01	206,375	0.00 (8.33%)
30-Oct	$0.01	111,168	0.00 (0.00%)
29-Oct	$0.01	83,000	0.00 (0.00%)
28-Oct	$0.01	189,047	+0.00 (9.09%)
27-Oct	$0.01	300,923	0.00 (0.00%)
26-Oct	$0.01	20,000	0.00 (0.00%)
23-Oct	$0.01	16,950	0.00 (0.00%)
22-Oct	$0.01	0	0.00 (0.00%)
3 up, 5 down, and 7 flat days

Cynata Therapeutics Health Care
Cancer Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

Upcoming Floats (8)

End of Day Prices

Cynata Therapeutics Health Care Cancer Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

Upcoming Floats (8)

End of Day Prices

Cynata Therapeutics Health Care
Cancer Healthcare